Evidence map›Paper›PMID 38791338›Full record

ReviewInternational journal of molecular sciences2024

In the Eyes of the Beholder-New

Sourav Ghosh, Silvia C Finnemann, Douglas Vollrath, Carla V Rothlin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Mertk signaling and immune regulation in T cells.Journal of leukocyte biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sourav GhoshDepartment of Neurology, School of Medicine, Yale University, New Haven, CT 06520, USA.ORCID 0000-0001-5990-8708
Silvia C FinnemannCenter for Cancer, Genetic Diseases and Gene Regulation, Department of Biological Sciences, Fordham University, Bronx, NY 10458, USA.ORCID 0000-0001-9298-0736
Douglas VollrathDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Carla V RothlinDepartment of Pharmacology, School of Medicine, Yale University, New Haven, CT 06520, USA.

Funding

Inflammation in MERTK-dependent retinitis pigmentosaR01EY034003 · NEI · YALE UNIVERSITY · PI SILVIA C FINNEMANN, Sourav Ghosh · 2023 to 2026
$2.6M
Anti-inflammatory role of MerTK in the RPE independent of diurnal outer segment phagocytosisR21EY033188 · NEI · FORDHAM UNIVERSITY · PI FINNEMANN, SILVIA C · 2021 to 2022
$436k
NEI NIH HHS 1R01EY034003NEI NIH HHS 1R21EY033188NEI NIH HHS 5R01EY03400202NEI NIH HHS R01 EY034003NEI NIH HHS R21 EY033188
6 · The paper itself

Abstract

Greg Lemke's laboratory was one of the pioneers of research into the TAM family of receptor tyrosine kinases (RTKs). Not only was

Indexed as

c-Mer Tyrosine KinaseMice, KnockoutPhagocytosisAnimalsDisease Models, AnimalHumansInflammationMiceReceptor Protein-Tyrosine KinasesRetinal Degenerationc-Mer Tyrosine KinaseMertk protein, mouseReceptor Protein-Tyrosine KinasesinflammationMERTKRetinitis PigmentosaTAM RTK

Identifiers

PMID38791338
PMCPMC11121519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.